Duchenne muscular dystrophy (DMD) is an incurable genetic condition which causes the muscles to slowly stop working. Most ...

Keros Therapeutics, Inc.'s stock plummets 75% due to safety concerns in Phase 2 trial, but partnership with Takeda may offer ...

Mesenchymal stem cells, or MSCs, have been an area of interest for decades and have shown efficacy in treating inflammation-driven diseases beyond heart failure, including chronic lower-back pain.

A new study found that taking a break from resistance training doesn’t significantly impact your overall strength in the long ...

CELLEV8 Launches First Post-GLP-1 Gummy Supplement: "SlimCell™" with Clinically Proven Ingredients to Compliment GLP-1 ...

Jefferies and Piper Sandler are acting as joint book-running managers and representatives of the underwriters for the ...

On Power Athlete Radio, Dr. Heller and I explored the science behind hypertrophy and how cooling can play a key role in maximizing training effects. While the e ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offerin ...

Unlock game-changing treatments and expert tips to smooth out forehead wrinkles and reveal younger-looking skin.

Avidity Biosciences' AOC platform shows promising results for genetic diseases, making it a strong buy with potential upside ...